Nanoparticle formulation for controlled release of capsaicin.
Seon Kim1, Jong Chul Kim, Donggeun Sul
1Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, Oryong-dong, Buk-gu, Gwangju 500-712, Korea.
Journal of Nanoscience and Nanotechnology
|July 26, 2011
Summary
Researchers developed sustained-release capsaicin nanoparticles for discogenic back pain. Poly(L-lactic acid) nanoparticles achieved a month-long release, offering a promising new treatment option.
Area of Science:
- Pharmacology
- Biomaterials Science
- Nanotechnology
Background:
- Discogenic back pain is a significant health issue.
- Capsaicin shows potential for pain management and neuroprotection.
- Current treatments may have limitations in efficacy and duration.
Purpose of the Study:
- To formulate capsaicin-loaded nanoparticles for sustained drug delivery.
- To investigate nanoparticle characteristics and drug release profiles.
- To explore potential applications in treating discogenic back pain.
Main Methods:
- Capsaicin-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared using nano-precipitation.
- Modified single emulsion solvent evaporation/extraction method was used with poly(L-lactic acid) (PLLA), PLGA, and poly(ε-caprolactone) (PCL).
- Particle size, drug loading efficiency, and in vitro drug release were analyzed.
Main Results:
- Nano-precipitation yielded particles with release durations of 5-11 days.
- PLLA nanoparticles demonstrated significantly more sustained release compared to PLGA and PCL.
- PLLA particles of 800 nm achieved approximately 1 month of capsaicin release with high drug-loading efficiency.
Conclusions:
- Biocompatible nanoparticles can be formulated for controlled capsaicin release.
- Formulations achieved sustained release from 1 week to 1 month.
- These findings suggest potential for capsaicin nanoparticles in managing discogenic back pain.
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...